ASCENTRA-UC expected to enroll up to 204 patients with moderately to severely active ulcerative colitis across North America ...

U.S.-listed shares of Abivax climbed more than 25% in after-hours trading after the French biotech released new data aimed at ...

June 29 (Reuters) - Abivax said on Monday its experimental ulcerative colitis drug helped harder-to-treat groups of patients achieve remission, with the biotech calling the results a boost to the ...

French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ...

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative ...

Hyperbaric oxygen therapy was well tolerated in treatment-refractory ulcerative colitis and enhanced clinical outcomes alongside improved bowel perfusion.

Amebic Colitis is caused by the anaerobic parasitic amoebozoan Entameba histolytica. This bacterium infects the mucosa in the colon and accounts for 100,000 deaths annually. The parasite infects 10% ...

'Imagine having a wound that never heals. Only it’s on the inside and every time you eat or drink, it’s like rubbing salt into that wound.' When asked to explain the sensation of ulcerative colitis, ...

Although there is no cure for ulcerative colitis, various treatments like medications, surgery, and home remedies can help manage symptoms and extend the time between flare-ups. Newer treatments, ...

Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.

Ulcerative colitis is a chronic condition that affects the large intestines, particularly the colon. It is classified as one of the two inflammatory bowel diseases along with Crohn’s disease. The ...